Skip to Content


In the US, Cetrorelix (cetrorelix systemic) is a member of the drug class gonadotropin-releasing hormone antagonists and is used to treat Ovulation Induction.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Gonadotropin releasing hormone (GnRH)-1-receptor antagonist

Chemical Names

Acetyl-3-(2-naphtyl)-D-alanyl-4-chlorphenyl-D-alanyl-3-(3-pyridyl)-D-alanyl-L-seryl-L-tyrosyl-N'-carbamoyl-D-ornityl-L-leucyl-L-arginyl-L-prolyl-D-alaninamid (IUPAC)

N-Acetyl-3-(2-naphtyl)-D-alanyl-p-chloro-D-phenylalanyl-3-(3-pyridyl)-D-alanyl-L-seryl-L-tyrosyl-N5-carbamoyl-D-ornityl-L-leucyl-L-arginyl-L-prolyl-D-alanin-amide (WHO)

Foreign Names

  • Cetrorelixum (Latin)
  • Cetrorelix (German)
  • Cétrorélix (French)
  • Cetrorelix (Spanish)

Generic Names

Brand Names

  • Cetrotide
    Aeterna Zentaris, Serbia; Baxter, Latvia; Merck, Bosnia & Herzegowina; Merck, Colombia; Merck, Turkey; Merck Serono, Tunisia; Mottah., Egypt; Serono, Lebanon
  • Cetace
    Celon, India
  • Cetrotide
    Abbott, Georgia; ASTA Medica, Kuwait; Baxter, Georgia; Baxter Oncology GmbH, Serbia; EMD Serono, Canada; EMD Serono, United States; Healthcare Logistics, New Zealand; Merck, Brazil; Merck, Chile; Merck, Denmark; Merck, Finland; Merck, Greece; Merck, Hong Kong; Merck, Croatia (Hrvatska); Merck, Indonesia; Merck, South Korea; Merck, Luxembourg; Merck, Mexico; Merck, Norway; Merck, Philippines; Merck, Portugal; Merck, Sweden; Merck, Slovakia; Merck Consumer Healthcare, Belgium; Merck KGaA, Macedonia; Merck S.L., Spain; Merck Serono, Argentina; Merck Serono, Australia; Merck Serono, China; Merck Serono, Czech Republic; Merck Serono, Estonia; Merck Serono, France; Merck Serono, United Kingdom; Merck Serono, Ireland; Merck Serono, Iceland; Merck Serono, Italy; Merck Serono, Malaysia; Merck Serono, Netherlands; Merck Serono, Poland; Merck Serono, Romania; Merck Serono, Taiwan; Merck Serono, South Africa; Merck Serono Europe, Cyprus; Merck Specialties, India; Nippon Kayaku, Japan; Serono, Bangladesh; Serono, Venezuela; Serono Europe, Lithuania; Merck Merck Serono Division, Singapore
  • Cetrotide 0,25 mg
    Eurim-Pharm, Austria; Merck, Switzerland; Merck, Hungary; Merck Serono, Austria; Merck Serono, Germany
  • Cetrotide 0.25
    Baxter, Oman; Merck Serono Ltd, Israel


BANBritish Approved Name
DCFDénomination Commune Française
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.